PMC:7565665 / 79854-80304 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T452","span":{"begin":86,"end":93},"obj":"Body_part"},{"id":"T453","span":{"begin":119,"end":123},"obj":"Body_part"},{"id":"T454","span":{"begin":242,"end":246},"obj":"Body_part"}],"attributes":[{"id":"A452","pred":"fma_id","subj":"T452","obj":"http://purl.org/sig/ont/fma/fma67257"},{"id":"A453","pred":"fma_id","subj":"T453","obj":"http://purl.org/sig/ont/fma/fma7195"},{"id":"A454","pred":"fma_id","subj":"T454","obj":"http://purl.org/sig/ont/fma/fma7195"}],"text":"NV is the lead inventor on patent targeting proteostasis mechanisms for rescuing CFTR protein-processing defect and CF lung disease. NV is also the lead inventor of nano-based selective drug delivery and therapeutic targeting for obstructive lung diseases. NV is a founder of PRECISION THERANOSTICS INC and VIJ BIOTECH that focuses on the bench-side translation of novel respiratory therapeutics and declares that he has no other competing interests."}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T116","span":{"begin":119,"end":123},"obj":"Body_part"},{"id":"T117","span":{"begin":242,"end":246},"obj":"Body_part"}],"attributes":[{"id":"A116","pred":"uberon_id","subj":"T116","obj":"http://purl.obolibrary.org/obo/UBERON_0002048"},{"id":"A117","pred":"uberon_id","subj":"T117","obj":"http://purl.obolibrary.org/obo/UBERON_0002048"}],"text":"NV is the lead inventor on patent targeting proteostasis mechanisms for rescuing CFTR protein-processing defect and CF lung disease. NV is also the lead inventor of nano-based selective drug delivery and therapeutic targeting for obstructive lung diseases. NV is a founder of PRECISION THERANOSTICS INC and VIJ BIOTECH that focuses on the bench-side translation of novel respiratory therapeutics and declares that he has no other competing interests."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T527","span":{"begin":116,"end":118},"obj":"Disease"},{"id":"T528","span":{"begin":119,"end":131},"obj":"Disease"},{"id":"T529","span":{"begin":230,"end":255},"obj":"Disease"},{"id":"T530","span":{"begin":414,"end":416},"obj":"Disease"}],"attributes":[{"id":"A527","pred":"mondo_id","subj":"T527","obj":"http://purl.obolibrary.org/obo/MONDO_0009061"},{"id":"A528","pred":"mondo_id","subj":"T528","obj":"http://purl.obolibrary.org/obo/MONDO_0005275"},{"id":"A529","pred":"mondo_id","subj":"T529","obj":"http://purl.obolibrary.org/obo/MONDO_0002267"},{"id":"A530","pred":"mondo_id","subj":"T530","obj":"http://purl.obolibrary.org/obo/MONDO_0017319"}],"text":"NV is the lead inventor on patent targeting proteostasis mechanisms for rescuing CFTR protein-processing defect and CF lung disease. NV is also the lead inventor of nano-based selective drug delivery and therapeutic targeting for obstructive lung diseases. NV is a founder of PRECISION THERANOSTICS INC and VIJ BIOTECH that focuses on the bench-side translation of novel respiratory therapeutics and declares that he has no other competing interests."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T884","span":{"begin":81,"end":85},"obj":"http://purl.obolibrary.org/obo/PR_000001044"},{"id":"T885","span":{"begin":119,"end":123},"obj":"http://purl.obolibrary.org/obo/UBERON_0002048"},{"id":"T886","span":{"begin":119,"end":123},"obj":"http://www.ebi.ac.uk/efo/EFO_0000934"},{"id":"T887","span":{"begin":242,"end":246},"obj":"http://purl.obolibrary.org/obo/UBERON_0002048"},{"id":"T888","span":{"begin":242,"end":246},"obj":"http://www.ebi.ac.uk/efo/EFO_0000934"},{"id":"T889","span":{"begin":263,"end":264},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T890","span":{"begin":324,"end":331},"obj":"http://purl.obolibrary.org/obo/CLO_0009985"},{"id":"T891","span":{"begin":417,"end":420},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"}],"text":"NV is the lead inventor on patent targeting proteostasis mechanisms for rescuing CFTR protein-processing defect and CF lung disease. NV is also the lead inventor of nano-based selective drug delivery and therapeutic targeting for obstructive lung diseases. NV is a founder of PRECISION THERANOSTICS INC and VIJ BIOTECH that focuses on the bench-side translation of novel respiratory therapeutics and declares that he has no other competing interests."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T6664","span":{"begin":0,"end":2},"obj":"Chemical"},{"id":"T36631","span":{"begin":86,"end":93},"obj":"Chemical"},{"id":"T14237","span":{"begin":133,"end":135},"obj":"Chemical"},{"id":"T21034","span":{"begin":186,"end":190},"obj":"Chemical"},{"id":"T252","span":{"begin":257,"end":259},"obj":"Chemical"}],"attributes":[{"id":"A288","pred":"chebi_id","subj":"T6664","obj":"http://purl.obolibrary.org/obo/CHEBI_73825"},{"id":"A29222","pred":"chebi_id","subj":"T36631","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"},{"id":"A12610","pred":"chebi_id","subj":"T14237","obj":"http://purl.obolibrary.org/obo/CHEBI_73825"},{"id":"A82254","pred":"chebi_id","subj":"T21034","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"},{"id":"A73426","pred":"chebi_id","subj":"T252","obj":"http://purl.obolibrary.org/obo/CHEBI_73825"}],"text":"NV is the lead inventor on patent targeting proteostasis mechanisms for rescuing CFTR protein-processing defect and CF lung disease. NV is also the lead inventor of nano-based selective drug delivery and therapeutic targeting for obstructive lung diseases. NV is a founder of PRECISION THERANOSTICS INC and VIJ BIOTECH that focuses on the bench-side translation of novel respiratory therapeutics and declares that he has no other competing interests."}

{"project":"LitCovid-PubTator","denotations":[{"id":"1895","span":{"begin":81,"end":85},"obj":"Gene"},{"id":"1896","span":{"begin":311,"end":318},"obj":"Gene"},{"id":"1897","span":{"begin":371,"end":382},"obj":"Species"},{"id":"1898","span":{"begin":116,"end":131},"obj":"Disease"},{"id":"1899","span":{"begin":242,"end":255},"obj":"Disease"}],"attributes":[{"id":"A1895","pred":"tao:has_database_id","subj":"1895","obj":"Gene:1080"},{"id":"A1896","pred":"tao:has_database_id","subj":"1896","obj":"Gene:57449"},{"id":"A1897","pred":"tao:has_database_id","subj":"1897","obj":"Tax:12814"},{"id":"A1898","pred":"tao:has_database_id","subj":"1898","obj":"MESH:D003550"},{"id":"A1899","pred":"tao:has_database_id","subj":"1899","obj":"MESH:D008171"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"NV is the lead inventor on patent targeting proteostasis mechanisms for rescuing CFTR protein-processing defect and CF lung disease. NV is also the lead inventor of nano-based selective drug delivery and therapeutic targeting for obstructive lung diseases. NV is a founder of PRECISION THERANOSTICS INC and VIJ BIOTECH that focuses on the bench-side translation of novel respiratory therapeutics and declares that he has no other competing interests."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T219","span":{"begin":119,"end":131},"obj":"Phenotype"},{"id":"T220","span":{"begin":230,"end":255},"obj":"Phenotype"}],"attributes":[{"id":"A219","pred":"hp_id","subj":"T219","obj":"http://purl.obolibrary.org/obo/HP_0002088"},{"id":"A220","pred":"hp_id","subj":"T220","obj":"http://purl.obolibrary.org/obo/HP_0006536"}],"text":"NV is the lead inventor on patent targeting proteostasis mechanisms for rescuing CFTR protein-processing defect and CF lung disease. NV is also the lead inventor of nano-based selective drug delivery and therapeutic targeting for obstructive lung diseases. NV is a founder of PRECISION THERANOSTICS INC and VIJ BIOTECH that focuses on the bench-side translation of novel respiratory therapeutics and declares that he has no other competing interests."}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T1006","span":{"begin":81,"end":85},"obj":"http://purl.obolibrary.org/obo/GO_0005260"},{"id":"T1007","span":{"begin":86,"end":104},"obj":"http://purl.obolibrary.org/obo/GO_0016485"},{"id":"T1008","span":{"begin":350,"end":361},"obj":"http://purl.obolibrary.org/obo/GO_0006412"}],"text":"NV is the lead inventor on patent targeting proteostasis mechanisms for rescuing CFTR protein-processing defect and CF lung disease. NV is also the lead inventor of nano-based selective drug delivery and therapeutic targeting for obstructive lung diseases. NV is a founder of PRECISION THERANOSTICS INC and VIJ BIOTECH that focuses on the bench-side translation of novel respiratory therapeutics and declares that he has no other competing interests."}

{"project":"LitCovid-sentences","denotations":[{"id":"T426","span":{"begin":0,"end":132},"obj":"Sentence"},{"id":"T427","span":{"begin":133,"end":256},"obj":"Sentence"},{"id":"T428","span":{"begin":257,"end":450},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"NV is the lead inventor on patent targeting proteostasis mechanisms for rescuing CFTR protein-processing defect and CF lung disease. NV is also the lead inventor of nano-based selective drug delivery and therapeutic targeting for obstructive lung diseases. NV is a founder of PRECISION THERANOSTICS INC and VIJ BIOTECH that focuses on the bench-side translation of novel respiratory therapeutics and declares that he has no other competing interests."}